Cibus Global LLC
Price & Volume
Stats
See moreOpen | $1.76 |
Previous Close | $1.91 |
Day Range | $1.73-$1.76 |
52W Range | $1.75-$21.23 |
Market Cap | $65.6M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $4.2M |
Revenue Growth (YoY) | 9.9% |
Gross Profit (12 Mos) | $4.2M |
Diluted EPS | -$10.83 |
News
See moreYahoo Finance • 14 days ago
Cibus Reports Fourth Quarter Financial Results and Provides Business Update
Yahoo Finance • 17 days ago
Cibus Welcomes the European Union’s Progress as Legislation for New Genomic Techniques to Boost Innovation and Sustainability Moves Forward
Yahoo Finance • 23 days ago
Cibus to Report Fourth Quarter 2024 Financial Results on March 20, 2025 After the Market Close and Host Conference Call
Yahoo Finance • 30 days ago
Cibus’ Achieves Another Milestone for a Durable White Mold (Sclerotinia) Resistance Trait in Canola
About
CEO | Dr. Peter R. Beetham B.Sc., Ph.D. |
Address | 6455 Nancy Ridge Drive, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 157 |
